:quality(75)/dvgnzpfv30f28.cloudfront.net/10-13-2020/t_a853909a02684b2eb6079de99a41edab_name_Copia_de_PORTADAS_ARC_TRVSL.png)
Johnson & Johnson interrumpe ensayo de posible vacuna contra la COVID-19 por voluntario enfermo
El estudio buscaba inscribir hasta 60.000 voluntarios en alrededor de 215 lugares de investigación clínica.
- 13 de octubre de 2020 05:28 p.m.
- Duración: 02:01
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/LQZ5AGETRBGSPLTANGBBTIGQGY.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/7HAQSR6DSBESNC33RZBXRSZ3II.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JNXXOQ657BA2LFKY73N2RYWALE.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/H4QOXDtK/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/RaWoJY5Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/OW4BNTPJ/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/AKRCAPSLVRDKVG73ZS2CD7VGBU.png)
:quality(75)/cdn.jwplayer.com/v2/media/IFIV9x99/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/kdFkpt0E/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/n2UjFCbU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/K3aQiytQ/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/bMzAR6Bd/poster.jpg)